about
Does it make sense to target one tumor cell chemotactic factor or its receptor when several chemotactic axes are involved in metastasis of the same cancer?Modern Radiotherapy Concepts and the Impact of Radiation on Immune ActivationRadio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical ApplicationsAnticancer drugs for the modulation of endoplasmic reticulum stress and oxidative stressCell death-associated molecular-pattern molecules: inflammatory signaling and controlMénage à Trois in stress: DAMPs, redox and autophagyModulation of inflammation by autophagy: Consequences for human diseaseDifferent Toll-Like Receptor Expression Patterns in Progression toward Cancer"Eat me" imaging and therapyEssential versus accessory aspects of cell death: recommendations of the NCCD 2015.Inflammatory Response After Laparoscopic Versus Open Resection of Colorectal Liver Metastases: Data From the Oslo-CoMet TrialEmerging role of HMGB1 in lung diseases: friend or foe.Ceramide and sphingosine-1-phosphate act as photodynamic therapy-elicited damage-associated molecular patterns: cell surface exposureTreatment of osteosarcoma with microwave thermal ablation to induce immunogenic cell deathUpregulation of heat shock proteins and the promotion of damage-associated molecular pattern signals in a colorectal cancer model by modulated electrohyperthermia.Combinatorial strategies for the induction of immunogenic cell death.DAMPs, ageing, and cancer: The 'DAMP Hypothesis'.The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 MelanomaPre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP componentsExtracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells.Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner.Immunogenic cell death due to a new photodynamic therapy (PDT) with glycoconjugated chlorin (G-chlorin).ER-mediated control for abundance, quality, and signaling of transmembrane immune receptors in plants.Mechanisms of therapeutic resistance in cancer (stem) cells with emphasis on thyroid cancer cells.The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines.TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells.Iron, oxidative stress, and redox signaling in the cardiovascular system.The Role of Damage-Associated Molecular Patterns (DAMPs) in Human Diseases: Part II: DAMPs as diagnostics, prognostics and therapeutics in clinical medicine.The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cellsImmunogenic Apoptotic Cell Death and Anticancer Immunity.Radiotherapy and immunotherapy: a beneficial liaison?Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors.Engineering challenges for brain tumor immunotherapy.Surgical and immune reconstitution murine models in bone marrow research: Potential for exploring mechanisms in sepsis, trauma and allergy.Synergistic effect of high-mobility group box-1 and lipopolysaccharide on cytokine induction in bovine peripheral blood mononuclear cells.A 25-gene classifier predicts overall survival in resectable pancreatic cancer.Nanosecond-Pulsed DBD Plasma-Generated Reactive Oxygen Species Trigger Immunogenic Cell Death in A549 Lung Carcinoma Cells through Intracellular Oxidative StressConsensus guidelines for the detection of immunogenic cell death.No patient left behind: The promise of immune priming with epigenetic agents.
P2860
Q26741977-FD935F43-5BC6-498E-A778-9A61666F04BFQ26744490-1CEA4DDB-A93F-47A5-898D-650D1FB7B422Q26779221-EC4DD652-A10C-49B8-A293-CB68BF205293Q26799265-62391A69-F111-4E9D-A9EA-2BA571EC3673Q27014671-9D01C827-DD4A-46BE-8BA7-F585EC56B1DAQ27023542-F188C13D-CE29-4E3E-91CD-CFA5397341F3Q28082840-C0A7281F-720A-4F3F-BC01-259AEEEA4A69Q28085163-DF61DF73-3318-4382-B10E-180A58E4B6AAQ28394148-FC3B2AA1-876A-4537-9AE7-58D1A8570829Q30408769-1CF24445-9C38-45D6-ACC8-B6B7280D94CCQ31010163-863771F0-8C08-4F36-B07B-1589EE84A142Q33684145-FBDDEE36-C130-4A85-A8F1-7421C043A161Q33705468-F8C4BAFB-35DE-42DD-8777-7D776B8CB75FQ34227797-6128F705-DF26-4549-B31A-CB204299C504Q34628990-1CEDF820-0AD3-4541-ABEE-5D2B4B99CBCBQ35535140-96B20488-E23A-4196-B7F8-6796EA17B34AQ35558632-42DFD2E8-F70F-4018-879A-F957B37D3695Q35924903-62B4F4F8-8631-4D31-BFA8-6FB98312BF3BQ36052673-FF196DEE-27AD-4A3A-AE62-9F22E0CD2FE5Q36092658-891C2B6F-5B6C-4B07-BD80-0BC09E8B9658Q36310954-D265A81E-A586-44FC-832E-C2B327AD74FFQ36346964-930F2F21-B0BA-4991-B806-47E5F52C7834Q37565103-9CD9CF5F-9CE1-495E-9BCA-22B3F92923F4Q37601636-4025E8B5-985B-433F-8FB7-4CA05186FF7FQ37676466-CF0AFF93-EA9B-4503-8BC1-4CE58425EB25Q37678815-658A2002-6329-45C7-AF75-E269FD130562Q37729984-12AA607F-72F5-4D59-A3C9-D7C598E67B47Q38216863-1EF47960-6411-4EF3-AF21-BE8ECA89D27BQ38519934-4D5E1644-277A-48EC-A1F2-3FF0698203EAQ38791198-8141C150-352A-4550-A356-9845F84D0E36Q38936705-70399A65-C958-44B4-AD66-6C68268D3CA6Q39017268-B843317C-FBD1-4368-BCC7-93A53C9E0B20Q39208496-03D85040-A227-410F-9695-079687501D20Q39381281-239B0A7A-2FF7-438A-91AD-9267276CC583Q40054505-EA4177DB-DE05-4E4E-8659-1D66EA19D383Q40239891-BC114768-70A5-4235-A227-87E1D331A884Q41711884-69266081-7946-4B1F-B958-6B8E1D3AFF50Q42229194-42716FC3-853C-49B6-BB59-7D0A6D3DAC4FQ42553556-BD8B9D8A-B649-43A2-A2E5-2B3385D1CF8EQ46665179-9514EB48-7F93-4541-81C0-85776C546162
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Many faces of DAMPs in cancer therapy.
@en
type
label
Many faces of DAMPs in cancer therapy.
@en
prefLabel
Many faces of DAMPs in cancer therapy.
@en
P2093
P2860
P356
P1476
Many faces of DAMPs in cancer therapy.
@en
P2093
D V Krysko
T Løve Aaes
P2860
P356
10.1038/CDDIS.2013.156
P5008
P577
2013-05-16T00:00:00Z